Genmab — Januar 2020

[AaBforever]

US 444 386
Row

[JStudsgaard]

US 444 ROW 385

[Goose3]

Vel skuffende med ROW. Måske rabatter igen!

[E_L]

There is a 5.3% negative currency impact on ROW sales, that is ~$13.83m in volume

[Solsen]

Just want to know who figurede out to save Genmab ?

[E_L]

i did not want to mention it Solsen..., but i wonder if we will ever find out if this was the exact calculation from the contract, or if Jan called in a favour from JNJ....

[Bella1]

[E_L]

but either way, it is done, and i am happy, i guess i wasn't as optimistic as most here as i thought we could just miss it, so very pleased we got the milestone

[E_L]

i actually said to Nike the other day, 15mn in currency impact could just make the difference of making the milestone or not lol

[Nike]

You nailed the main point, EL! NIce

[bikube]

Derfor Genmab hele tiden har budgetteret med $-kurs 6Kr.

[E_L]

credit to Genmab by the way for sending out their message just before JNJ's in order to avoid milestone-confusion. They learned from previous experiences...

[Sukkeralf]

Yes E L - that was great work by Genmab

[Solsen]

Great - could have been expensive for some.

[AaBforever]

GENMAB/SYDBANK: DARZALEX-SALGET RUNDER 4 MIA. DOLLAR I 2020.

[AaBforever]

• Vi estimerer et markedssalg for Darzalex på 4144 mio. dollar i 2020

[E_L]

on teprotumumab - i read 'the company explained that the full course requires 23 vials, setting the cost at $343,000 wholesale acquisition cost' and in their presentation 'Expected average net realized price: ~$200,000' https://endpts.com/fda-hands-off-its-latest-whirlwind-drug-ok-as-horizon-hustles-would-be-blockbuster-to-the-market/

[E_L]

that is a big difference...

[E_L]

@AaBforever that is very close to what Danske had in october, 4146...

[StockBull]

But cash-burn will increase and no milestone payments so 2020 will be more or less same profit / bottom-line as 2019. So interesting who the marked will react